Clinical Trial Update: Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating olanzapine for prevention and treatment of chemotherapy-induced nausea and vomiting in patients with lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Lung Cancer

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Zunyi Medical College | Conditions: Chemotherapy-induced Nausea and Vomiting, Lung Cancer | Phase 4 | Status: UNKNOWN